A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension

NCT02676947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Tocilizumab

Sponsor

Papworth Hospital NHS Foundation Trust

Collaborators

[object Object]
[object Object]